Skip to content


Mirapex, Mirapex Er, Mirapexin, Sifrol (pramipexole) is a small molecule pharmaceutical. Pramipexole was first approved as Mirapex on 1997-07-01. It is used to treat depressive disorder and parkinson disease in the USA. It has been approved in Europe to treat parkinson disease and restless legs syndrome. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. Mirapex's patents are valid until 2029-09-08 (FDA).
Trade Name Mirapexin, Sifrol
Common Name Pramipexole
Indication depressive disorder, parkinson disease, restless legs syndrome
Drug Class
Get full access now